Loading clinical trials...
Loading clinical trials...
A Randomized, Placebo-controlled, Double Blind, 4-period, Cross-over Trial, to Study the Effects of Aliskiren, Hydrochlorothiazide and Moxonidine on Endothelial Dysfunction in Obesity Related Hypertension
Conditions
Interventions
Aliskiren
Moxonidine
+3 more
Locations
1
Netherlands
UMC Utrecht
Utrecht, Utrecht, Netherlands
Start Date
August 1, 2010
Primary Completion Date
February 1, 2012
Completion Date
February 1, 2012
Last Updated
February 24, 2012
NCT02417740
NCT07480265
NCT07073820
NCT06876233
NCT07237750
NCT06062394
Lead Sponsor
UMC Utrecht
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions